UPPSALA, SWEDEN – Olink Bioscience has signed a distributor-ship agreement with Genetix Biotech Asia Pvt. Ltd for distribution of the Duolink® in situ PLA™ product line in India and south East Asian countries. This region repre-sents a new market for Olink Bioscience with an increasing number of academic and industrial customers.

“With Genetix Biotech we are pleased to have found the ideal partner to make our products available to customers in India and by this be able to offer this enabling tool to the fast growing research community in the Indian market.” says Peter Karl-berg, Director of Sales and Marketing at Olink Bioscience.

“We see a great potential for the PLA technology in the areas of academic and in-dustrial research in India. The Duolink reagents, using in situ PLA technology, repre-sent a breakthrough in the proteomics field and increase our ability to offer innovati-ve core technologies” says Dr. Ajmeer Khaja Sheriff, Technical Director at Genetix Biotech Asia (P) Ltd. “It is indeed our great pleasure to work with innovative techno-logy driven companies like Olink Bioscience which will address some of the key is-sues in the growing areas of protein research in situ analysis”, he adds.

The Duolink product line is based on Olink Bioscience proprietary in situ PLA, a proximity ligation assay technology that extends the capabilities of traditional immu-nofluorescence and immunohistochemistry to include direct detection of proteins, protein interactions and modifications with unparalleled specificity and sensitivity. Target proteins are detected with single molecule resolution, allowing digital quantifi-cation and information about the exact localization of the target. Furthermore, the proteins can be studied at normal expression levels in fixed cells and tissue sec-tions.

About Olink Bioscience

Olink Bioscience is a privately held biotech supply company based in Uppsala, Swe-den founded in 2004. The company controls significant IP covering technologies re-lated to detection and analysis of proteins and nucleic acids. These technologies are commercialized as proprietary Olink Bioscience products, in spin-out companies and in collaboration with external organization. In 2007 Olink Bioscience introduced the Duolink product line for in situ detection of proteins, protein interactions and pro-tein modifications. These products are based on PLA, a proximity ligation assays technology which use dual recognition of the analyte in combination with a DNA amplification based reporter system, resulting in unparalleled sensitivity and specifi-city. The technology is available as reagent kits and contract research projects thro-ugh Olink Bioscience.

About Genetix

Genetix is one of the largest service and products provider for Research and deve-lopment to the Indian academia, biopharmaceutical and clinical diagnostics segment for the last nineteen years with a large technically competent sales force covering entire territory of India and neighboring countries.

Duolink is intended for research use only. Duolink is not for use in human diagnostic or therapeutic procedures. The following trademarks are owned by Olink AB: Olink®, Olink Biosicence, Duolink® and PLA™.